Event time: 事件时间：
Published: 文章发布：
Key Results
Actual vs Consensus
EPS: $1.34 vs $1.20 estimate, beat+11.7%.Revenue: $5.5B vs $5.4B estimate, beat+3.0%.Profitability and Cash Flow
Period: 2026 Q3 period ended 2026-09-30Revenue: $5.5B; YoY: +7.2%; QoQ: +4.1%Gross profit: $2.2B; Gross margin: 40.3%Operating income: $805M; Operating margin: 14.6%; YoY: +23.3%; QoQ: +8.9%Net income: $615M; GAAP diluted EPS: $1.36; YoY: +37.9%; QoQ: +7.3%Operating cash flow: $227M; Capex: $114M; Free cash flow: $113MCash: $2.9B; Total debt: $3M; Net cash: $2.9BOfficial release: GE HealthCare reports third quarter 2026 financial results
核心结果
实际值与市场预期
EPS：$1.34 vs $1.20 预期，高于预期+11.7%。营收：$5.5B vs $5.4B 预期，高于预期+3.0%。财务指标
期间：2026 Q3（截至 2026-09-30）营收：$5.5B；同比：+7.2%；环比：+4.1%毛利润：$2.2B；毛利率：40.3%经营利润：$805M；经营利润率：14.6%；同比：+23.3%；环比：+8.9%净利润：$615M；GAAP 稀释 EPS：$1.36；同比：+37.9%；环比：+7.3%经营现金流：$227M；资本开支：$114M；自由现金流：$113M现金：$2.9B；总债务：$3M；净现金：$2.9B
